Keywords

HPV, vaccination, pediatric, quality improvement project, nurse practitioner

Abstract

Background: Human Papillomavirus (HPV) is the most common sexually transmitted infection in the United States. HPV vaccines are both safe and effective, providing long-lasting protection. Some organizations recommend the HPV vaccine should be initiated at age 9 years.

Specific Aims: The purpose of this pilot project was to improve HPV vaccination rates by 10% in patients ages 9-10 years at a large pediatric group. This purpose was accomplished through pediatric healthcare provider (HCP) education.

Methods: A quantitative and open-response questionnaire was used to determine HCPs’ confidence levels regarding the HPV vaccine at baseline. HCPs attended one evidence-based educational session. HPV vaccination rates from 4^th quarter 2022 were compared to 4^th quarter 2023.

Results: The number of HPV vaccines delivered to 9-10-year-old patients increased by 149 (61%) doses in 1 year. The total HPV vaccination, including all doses and among all patients, increased by 811 in 1 year. HCP confidence in HPV vaccine increases as children age. Factors influencing delay of HPV vaccination included parental hesitations and clinic expectations.

Discussion: There are multiple benefits to initiating HPV vaccination at the age of 9 years and HCP-focused education can improve vaccination rates in this age group. HCP education increases HPV vaccine confidence and, as a result, vaccination rates improve.

Conclusion: Pediatric Nurse Practitioners can and should conduct quality improvement projects to improve patients’ health by focusing on HPV vaccination rates, thus dramatically transforming HPV vaccine uptake and preventing HPV-related cancers for years to come.